Learn how evidence-based digital tools improve diabetes outcomes
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
8/16/2018: 12:00 AM
Ends On:
6/30/2019: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
1
Description:
Course Material
MUST be completed to acquire the validation code
Digital health interventions are a new and burgeoning field with limited literature to date. A specific series of recently published findings in the use of digital health interventions has demonstrated improved clinical outcomes in both trial and community. This course will teach providers in the community what a digital health intervention is for the patient and clinician, the indications for use, relay the newest findings from the literature, and demonstrate best practices for implementation in their own practices. The course will involve a series of modules including interactive web based teaching demonstration, summarized documents of the literature, and webinars, built for a busy practitioner.
Disclosures:
Speakers Bureau/Honoraria: Pfizer Pharmaceuticals
Speakers Bureau/Honoraria: Sanofi Genzyme
Research Support/Grants: Epharmix, Inc.
Allyson R. Zazulia, MD is a Professor of Neurology and the Associate Dean for Continuing Medical Education, Washington University School of Medicine in St. Louis. Dr. Zazulia has no financial relationships to disclose.
Avik Som, MD, PhD is a Resident Physician at Massachusetts General Hospital, Chief Medical Officer of Epharmix, Inc, and current sponsor and one of the former founding investigators of the Epharmix Research Center at Washington University in St. Louis.
Disclosures:
Service on a Board of Directors: Epharmix, Inc.
Ownership Interest/Stock Equity: Epharmix, Inc.
Kelly Dodds, NP is a Nurse Practitioner for Internal Medicine, Division of Hospital Medicine at Washington University School of Medicine in St. Louis. Kelly has no financial relationships to disclose.
Course Material
MUST be completed to acquire the validation code
Digital health interventions are a new and burgeoning field with limited literature to date. A specific series of recently published findings in the use of digital health interventions has demonstrated improved clinical outcomes in both trial and community. This course will teach providers in the community what a digital health intervention is for the patient and clinician, the indications for use, relay the newest findings from the literature, and demonstrate best practices for implementation in their own practices. The course will involve a series of modules including interactive web based teaching demonstration, summarized documents of the literature, and webinars, built for a busy practitioner.
Planning Committee
Will R. Ross, MD, MPH is a Professor of Medicine for the Department of Nephrology, Washington University School of Medicine in St. Louis.Disclosures:
Speakers Bureau/Honoraria: Pfizer Pharmaceuticals
Speakers Bureau/Honoraria: Sanofi Genzyme
Research Support/Grants: Epharmix, Inc.
Allyson R. Zazulia, MD is a Professor of Neurology and the Associate Dean for Continuing Medical Education, Washington University School of Medicine in St. Louis. Dr. Zazulia has no financial relationships to disclose.
Avik Som, MD, PhD is a Resident Physician at Massachusetts General Hospital, Chief Medical Officer of Epharmix, Inc, and current sponsor and one of the former founding investigators of the Epharmix Research Center at Washington University in St. Louis.
Disclosures:
Service on a Board of Directors: Epharmix, Inc.
Ownership Interest/Stock Equity: Epharmix, Inc.
Kelly Dodds, NP is a Nurse Practitioner for Internal Medicine, Division of Hospital Medicine at Washington University School of Medicine in St. Louis. Kelly has no financial relationships to disclose.
Objectives:
EpxDiabetes helps reduce HgbA1c while increasing patient engagement–even for the toughest patients. The course will involve an interactive web based teaching demonstration, summarized documents of the literature, and webinars, built for a busy practitioner. The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Define what a digital health intervention is and how clinicians can utilize the collection of patient-reported metrics to improve patient health outcomes.
- List recent improvements in diabetic outcomes, patient engagement, and patient satisfaction by using patient friendly tools.
- Describe the timely impact of asking the right evidence-based questions at the right frequency to help lower blood sugar levels.
Additional Information:
Target Audience
This course is designed for C-Suite, CMO, CMIO, CNO, Population Health, ACO leadership, Physicians, PAs, RNs.
Publication Date: August 16, 2018
Expiration Date: June 30, 2019
Target Audience
This course is designed for C-Suite, CMO, CMIO, CNO, Population Health, ACO leadership, Physicians, PAs, RNs.
Publication Date: August 16, 2018
Expiration Date: June 30, 2019
Accreditation Information:
In support of improving patient care, this activity has been planned and implemented by Epharmix and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity
In support of improving patient care, this activity has been planned and implemented by Epharmix and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 ANCC contact hours.
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 ANCC contact hours.
References:
- Peters RM, Lui M, Patel K, Tian L, Javaherian K, Sink E, Xu R, Xu Z, Aung W, Zhou L, Huynh J, Polites G, Blanchard M, Som A, Ross W, Bernal-Mizrachi C. Improving Glycemic Control With a Standardized Text-Message and Phone-Based Intervention: A Community Implementation. JMIR Diabetes 2017;2(2):e15.
- Peters, et. al. Washington University in St. Louis, in preparation.
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Category:
Epharmix
